eMedicine Specialties > Pediatrics: Developmental and Behavioral > Medical Topics
Anxiety Disorder: Generalized Anxiety
Updated: Sep 18, 2006
Introduction
Background
Generalized anxiety disorder (GAD) was introduced in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), replacing overanxious disorder of childhood (Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition [DSM-III-R]). GAD is associated with persistent, excessive, and unrealistic worry that is not focused on a specific object or situation.
Children with GAD worry more often and more intensely than other children in the same circumstances. They may worry excessively about their performance and competence at school or in sporting events, about personal safety and the safety of family members, or about natural disasters and future events.
The focus of worry may shift, but the inability to control the worry persists. Because children with GAD have a hard time "turning off" the worrying, their ability to concentrate, process information, and engage successfully in various activities may be impaired. In addition, problems with insecurity that often result in frequent seeking of reassurance may interfere with their personal growth and social relationships. Further, children with GAD often seem overly conforming, perfectionistic, and self-critical. They may insist on redoing even fairly insignificant tasks several times to get them "just right." This excessive structuring of one's life is used as a defense against the generalized anxiety related to the concern about the individual's overall and specific performance.
Pathophysiology
Little empiric data are available regarding the physiologic indicators of anxiety in children (Barrios, 1988; Beidel, 1988). The high cost, lack of normative data, idiosyncratic patterns, and high sensitivity of cardiovascular and electrodermal measures in children contribute to the difficulties in physiologic assessment of anxiety in children (Kendall, 2000).
Frequency
United States
Prevalence for children and adolescents ranges from 2.9-4.6%. GAD is more common in adolescents (aged 12-19 y) than in children (aged 5-11 y).
International
Worldwide prevalence of GAD is unknown.
Mortality/Morbidity
- Deaths related to GAD in childhood and adolescence are related more to comorbid conditions such as depression than to GAD. Children and adolescents with both depression and an anxiety disorder tend to have more severe forms of depression; therefore, GAD should be viewed as a risk factor for morbidity and mortality.
- Anxiety disorders have a high rate of comorbidity. Children with GAD are also likely to meet criteria for other anxiety disorders and, to a lesser degree, for a depressive or disruptive behavior disorder.
- Anxiety disorders tend to be unstable over time. That is, a child may struggle with anxiety for a long period, but it may not necessarily be a result of the same specific anxiety disorder.
- Anxiety is a serious problem in children and adolescents. We now understand that, in addition to deleteriously affecting the child's social and academic functioning (Pine, 1997), anxiety can cause serious long-term consequences. Many children with one of the anxiety disorders suffer intermittently for the rest of their lives. Other serious psychiatric conditions, such as major depressive disorder and substance misuse; these are closely associated with pediatric anxiety if not treated in a timely and effective manner.
- GAD also may co-occur with conditions associated with stress, such as irritable bowel syndrome and headaches. The long-term physiologic effects of stress are more likely to cause nonpsychiatric gastrointestinal, cardiovascular, or other sequelae later in life.
Race
Specific racial or cultural group prevalence rates are not available.
Sex
In childhood, the sex distribution tends to be equal for females and males. In adolescence, a female-to-male ratio of 6:1 has been suggested; however, epidemiologic study results vary.
Age
The age of onset varies. GAD is more common in adolescents and older children than in young children. In addition, affected adolescents and older children tend to have more symptoms than affected younger children.
Clinical
History
An evaluation for GAD should include data gathering through diagnostic interviews with the child and parent, direct observation, and questionnaires. Family history of anxiety and mood disorders, the child's early temperament and adjustment to school, and life stressors or disruptions are among important factors to consider in GAD.
- Structured interviews yielding DSM-IV diagnoses, such as the Diagnostic Interview Schedule for Children (DISC) and the Anxiety Disorders Interview Schedule for DSM-IV Child and Parent Versions (ADIS-C/P), can be employed.
- Questionnaires such as the Revised Children's Manifest Anxiety Scale (RCMAS), the Multidimensional Anxiety Scale for Children (MASC), and the Screen for Child Anxiety Related Emotional Disorders (SCARED) child and parent versions can be used to further assess anxiety symptoms.
- The DSM-IV requires the following to satisfy a diagnosis of GAD:
- Excessive anxiety and worry, occurring more days than not for at least 6 months, about a number of events or activities
- Difficulty controlling the worry
- One of the following symptoms in association with the worry: restlessness, fatigue, poor concentration, irritability, muscle tension, or sleep disturbance
- Focus of worry that is not confined to features of another Axis I diagnosis, eg, worry about having a panic attack, social embarrassment, or separation from caregiver
- Clinically significant distress or impairment experienced in social, school, or other important areas
- Disturbance not due to a substance or general medical condition and does not occur exclusively during a mood disorder, a psychotic disorder, or associated with a pervasive developmental disorder
Physical
Children with GAD may experience somatic symptoms such as shortness of breath, rapid heart beat, sweating, nausea or diarrhea, frequent urination, cold and clammy hands, dry mouth, trouble swallowing, or a "lump in the throat." Problems with muscle tension also can occur, including trembling, twitching, a shaky feeling, and muscle soreness or aches. Patients often complain of stomachaches and headaches. Despite these symptoms, few findings are noted on physical examination.
Excessive laboratory exclusion of somatic complaints is to be avoided; however, careful interview and physical examination assessment of stress-related symptoms should be repeated if the psychological diagnostic picture is unclear.
Causes
Multiple factors are thought to contribute to the development of GAD and to the broad category of anxiety disorders. Biological, familial, and environmental factors are considered important. Behavioral inhibition (Kagan, 1989), an early temperament associated with aversion to novel situations, has been found to be associated with later development of anxiety disorders.
Research has demonstrated an association between parents with anxiety disorders and children with behavioral inhibition. The tendency of anxiety to occur in families also has been established. Anxious parents may genetically predispose their children to anxiety, model anxious behavior, and behave and/or parent in ways that encourage and maintain anxious behavior in the child. Environmental factors, such as other parental emotional problems, disrupted attachment, stressful life events, and traumatic experiences, also may place the child at risk for developing GAD. The role of the family in understanding child anxiety is important, particularly in situations in which the needs of younger children who are developmentally limited in their ability to benefit from direct individual intervention are considered.
More on Anxiety Disorder: Generalized Anxiety |
Overview: Anxiety Disorder: Generalized Anxiety |
| Differential Diagnoses & Workup: Anxiety Disorder: Generalized Anxiety |
| Treatment & Medication: Anxiety Disorder: Generalized Anxiety |
| Follow-up: Anxiety Disorder: Generalized Anxiety |
| References |
| Next Page » |
References
AACAP. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. Oct 1998;37(10 Suppl):63S-83S. [Medline].
APA. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Elk Grove, Ill: APA; 1994.
APA. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Elk Grove, Ill: APA; 1987.
Barrett PM, Dadds MR, Rapee RM. Family treatment of childhood anxiety: a controlled trial. J Consult Clin Psychol. Apr 1996;64(2):333-42. [Medline].
Barrios BA, Hartmann DB. Fears and anxieties. In: Marsh EJ, Terdal LG, eds. Behavioral Assessment of Childhood Disorders. 2nd ed. New York, NY: Guilford;1988:196-264.
Beidel DC. Psychophysiological assessment of anxious emotional states in children. J Abnorm Psychol. Feb 1988;97(1):80-2. [Medline].
Birmaher B, Brent DA, Chiappetta L, et al. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. Oct 1999;38(10):1230-6. [Medline].
Green WH. Child and Adolescent Clinical Psychopharmacology. 3rd ed. Lippincott Williams & Wilkins;2001.
Kagan J. Temperamental contributions to social behavior. Am Psychol. 1989;44:668-74.
Kendall PC. Childhood Disorders. London, England: Psychology Press;2000.
Kendall PC, Chu BC, Pimental SS. Treating anxiety disorders in youth. In: Kendall PC, ed. Child & Adolescent Therapy: Cognitive-Behavioral Procedures. 2nd ed. New York, NY: Guilford;2000:235-287.
Last CG, Hansen C, Franco N. Cognitive-behavioral treatment of school phobia. J Am Acad Child Adolesc Psychiatry. Apr 1998;37(4):404-11. [Medline].
Last CG, Perrin S, Hersen M, Kazdin AE. A prospective study of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. Nov 1996;35(11):1502-10. [Medline].
Manassis K. Keys to Parenting Your Anxious Child. Hauppage, NY: Barron's Educational Series; 1996.
March JS, Parker JD, Sullivan K, et al. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry. Apr 1997;36(4):554-65. [Medline].
Pohl RB, Feltner DE, Fieve RR, Pande AC. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharmacol. Apr 2005;25(2):151-8. [Medline].
Reynolds CR, Richmond BO. What I think and feel: a revised measure of children's manifest anxiety. J Abnorm Child Psychol. Jun 1978;6(2):271-80. [Medline].
Shaffer D, Fisher P, Dulcan MK, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC- 2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry. Jul 1996;35(7):865-77. [Medline].
Silverman WK, Albano AM. The Anxiety Disorders Interview Schedule for Children (DSM-IV). San Antonio, Tex: The Psychological Corporation; 1997.
Silverman WK, Kurtines WM, Ginsburg GS, et al. Treating anxiety disorders in children with group cognitive-behaviorial therapy: a randomized clinical trial. J Consult Clin Psychol. Dec 1999;67(6):995-1003. [Medline].
Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. Jan 2006;163(1):41-7. [Medline]. [Full Text].
Spence S. Helping Your Anxious Child: A Step-By-Step Guide for Parents. Oakland, Calif: New Harbinger Publications; 2000.
Further Reading
Keywords
anxiety disorder, generalized anxiety, overanxious disorder, overanxious reaction, generalized anxiety disorder of childhood, generalized anxiety disorder, GAD
Overview: Anxiety Disorder: Generalized Anxiety